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ABSTRAK 
Pengenalan: 
Pelalian adalah salah satu kaedah yang telah terbukti keberkesanannya dalam 
mencegah sesetengah penyakit berjangkit. Namun begitu, komplians terhadap 
jadual pelalian yang disarankan selalunya tidak dipatuhi, terutamanya di 
kalangan kanak-kanak prasekolah. Ini seterusnya menghadkan keberkesanan 
pelalian itu sendiri. Pengenalpastian factor-faktor risiko kelewatan I 
ketidaklengkapan pelalian diharap dapat membantu meningkatkan lagi liputan 
pelalian. 
Objektif: 
Menentukan kadar peratusan kelewatan I ketidaklengkapan pelalian di 
kalangan kanak-kanak prasekolah yang dimasukkan ke wad di Hospital Sains 
Malaysia (HUSM) dan mengenalpasti factor-faktor risiko berkaitan dengan 
kelewatan tersebut. 
Metodologi: 
Kajian hirisan lintang berdasarkan hospital telah dijalankan di Hospital Universiti 
Sains Malaysia (HUSM) dari bulan Disember 1998 sehingga Disember 2000. 
Seramai 401 kanak-kanak berusia 1 bulan hingga 2 tahun yang telah 
dimasukkan ke wad kanak-kanak dikaji. Kanak-kanak tanpa documentasi tarikh 
pelalian yang diberikan telah dikecualikan dari kajian. Ibubapa atau penjaga 
telah ditemuramah menggunakan pro forma piawai setelah mendapat 
persetujuan lisan. Soalan-soalan yang dikemukakan meliputi data demografi 
kanak-kanak dan keluarga, tarikh pemberian pelalian serta alasen-alasan jika 
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kanak-kanak tersebut terlewat I tidak lengkap pelaliannya. Faktor-faktor risiko di 
antara kanak-kanak yang lengkap pelaliannya dengan kanak-kanak yang 
terlewat I tidak lengkap pelaliannya telah dibandingkan. 
Keputusan: 
Oi kalangan 401 kanak-kanak yang dikaji, 152 (37.90/0) daripadanya lengkap 
status pelaliannya, 108 (26.9%) lagi lewat pelaliannya, manakala 141 (35.20/0) 
lagi pelaliannya tidak lengkap. Liputan bagi vaksin Bacille-Calmitte-Guerin 
(BCG) adalah yang tertinggi (98.5%), manakala liputan campak adalah yang 
terendah (78.6%). Julat liputan vaksin bagi ketiga-tiga dos Hepatitis B adalah di 
antara 81.4%-98.30/0 manakala bagi ketiga-tiga dos OPV/DPT adalah di antara 
78.8%-90.7%. Kanak-kanak prasekolah yang di masukkan ke wad yang 
mempunyai ibu-ibu yang lanjut usia (~ 41 tahun) (OR 7.5, 950/0 CI: 1.6-35.6), 
yang mengalami kekurangan berat badan semasa lahir (~ 2.0 kg) (OR 5.7, 950/0 
CI: 1.7-19.4) serta mengalami penyakit yang kronik (OR 4.1, 950/0 CI: 2.4-7.3) 
didapati mempunyai perhubungan yang paling kuat dengan risiko kelewatan I 
ketidaklengkapan pelalian. Salah anggap terhadap kontraindikasi petalian di 
kalangan ibubapa (47.40/0) dan staf-staf kesihatan (42.70/0) adalah alasan 
utama yang diberikan oleh ibubapa terhadap kelewatan pelalian anak-anak 
mereka. 
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Kesimpulan: 
Sebilangan basar kanak-kanak prasekolah yang dimasukkan ke wad masih 
mengalami masalah kelewatan/ketidaklengkapan pelalian, walaupun kempen-
kempen pelalian giat dijalankan di peringkat kebangsaan. Faktor-faktor risiko 
yang dikenalpasti dalam kajian ini diharap dapat mengatasi masalah tersebut 
dengan mengunakan setiap peluang yang ada dengan sebaik-baiknya untuk 
memberi pelalian. Liputan bagi vaksin-vaksin yang diberikan pada umur yang 
lebih kemudian didapati lebih rendah daripada vaksin-vaksin yang diberikan 
pad a awal usia. Penemuan kajian ini diharap memberi lebih kesedaran di 
kalangan pekerja-pekerja kesihatan untuk mengenalpasti kanak-kanak yang 
berisiko tinggi untuk kelewatan pelalian serta mengambil langkah-Iangkah yang 
sewajarnya untuk mengatasi masalah tersebut. 
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ABSTRACT 
Introduction: 
Immunisations have been a very effective means for prevention of diseases. 
However, compliance with recommended schedules of immunisation in early 
childhood is not always complete, thus limiting the efficacy of these vaccines. 
Identification of potential risk factors associated with delayed I incomplete 
immunisation may help to increase the vaccination uptake. 
Objectives: 
The aims of this study were to determine the proportion of delayed I incomplete 
immunisation in hospitalised preschool children in Universiti Sains Malaysia 
Hospital (HUSM) and to identify risk factors for delayed I incomplete 
immunisation. 
Methodology: 
A hospital-based cross-sectional study was conducted at Universiti Sains 
Malaysia Hospital (HUSM) from December 1998 to December 2000. A total of 
401 children aged 1 month to 2 years from the medical paediatric wards were 
recruited for the study. Children without proper documentation of dates of 
vaccination were excluded. Parents I guardians were interviewed using a 
standard pro forma containing questions on demographic data, immunisation 
status, potential risk factors and reasons for delayed I incomplete immunisation 
after obtaining a verbal consent. Potential risk factors between children with 
complete and delayed I incomplete immunisation were compared. 
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Results: 
Among 401 children, 152 (37.90/0) had complete immunisation, 108 (26.90/0) had 
delayed immunisation and 141 (35.20/0) had incomplete immunisation. The 
vaccination uptake for Bacillus-Calmite-Guerin (BCG) was the highest (98.50/0) 
while for measles was the lowest (78.60/0). The range of uptake for the three 
doses of Hepatitis B was between 81.4%-98.30/0 and for the three doses of 
DPT/OPV was between 78.80/0-90.7%. Significant independent risk factors for 
delayed I incomplete immunisation were elderly mothers (~ 41 years old) (OR 
7.5,950/0 CI: 1.6-35.6), low birth weight ~2.0 kg (OR 5.7; 95% CI: 1.7-19.4) and 
presence of chronic illness (OR 4.1; 950/0 CI: 2.4-7.3). Misconceptions to 
contraindications of immunisation by parents (47.40/0) and health personnels 
(42.7%) was the most common reason given for delayed I incomplete 
immunisation. 
Conclusion: 
Despite a national campaign on immunisation, a large proportion of hospitalised 
preschool children were still underimmunised. Risk factors identified in this 
study should not lead to underimmunisation if every opportunity is taken to 
immunise children. Vaccines that were given at a later age were more likely to 
have lower vaccination uptake. The findings of this study should create more 
awareness among health care providers to identify children at risk for 
underimmunisation and to intervene appropriately. 
xii 
1. INTRODUCTION: 
1.1 Background of the study 
Immunisations have been a very effective means for prevention of diseases (Tift 
& Lederman, 1988). It is one of the most cost effective of all public health 
measures. Each year, millions of children worldwide receive vaccines to protect 
them from diseases such as measles, diphtheria, tetanus and poliomyelitis, 
which were highly prevalent prior to introduction of immunisation. Now, in many 
countries these diseases are rare. 
Diphtheria, pertussis, tetanus, oral poliovirus, measles, mumps rubella and 
Haemophilus influenza b (Hib) vaccines are immunogenic and confer a high 
degree of protection to children when administered at appropriate intervals 
(Centers for Disease Control & Prevention, 1994). Although combined vaccines 
have been in use worldwide for several decades, effective vaccines for hepatitis 
Band Haemophilus influenzae type B (Hib) have only become available in 
recent years and have yet to be adopted onto the vaccination programmes of 
many countries. 
Immunisation is a key component of preventive health care in children, as 
exemplified by the eradication of smallpox and the recent dramatic decline of 
invasive Haemophilus influenzae disease with immunisation (Vadheim, 1994; 
Gorelick, 1994; Centers for Disease Control & Prevention, 1994a & 1994b). 
Vaccination has been tremendously successful in decreasing the incidence of 
vaccine-preventable diseases. For example, the total number of measles cases 
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among US children dropped from 458,083 in 1964 (the year before widespread 
use of measles vaccine began) to 89 cases in 1998 (Centers for Disease 
Control and Prevention, 1997; Zimmerman et ai, 2000). Cases of Haemophilus 
influenza type b (Hib) disease among children in United States have also 
dropped dramatically, from an estimated 20,000 annually (Table 1) before 
introduction of Hib vaccine to 228 in1998 (Zimmerman et ai, 2000). 
Table 1. Diseases of children in the years before vaccines were 
routinely used (adapted from Zimmerman et ai, 2000) 
----------~------------------~--------~--------Year* No.of No.of No.of cases Diseases 
HepaiitisS-------------;f989 
Haemophilus influenza 
Invasive disease 1986 
MeningitiS 
Poliomyelitis 
All types 1954 
Paralytic 
Measles 1964 
Rubella 1970 
cases deaths in 1998 
~-;.----.,.-.------------
132,000 5820 8651 
13,014 
8676 
56,784 
18,308 
458,083 
57,686 
531 
354 
o 
o 
380 
o 
228 
1 
o 
89 
345 
There is strong evidence, supporting the benefit of the vaccines for the 
prevention of diseases (Gershon et ai, 1997). Impressive benefit to cost ratios 
have been shown in the United States for measles (12:1), rubella (8:1) and 
2 
pertussis (11: 1) vaccines (Nicoll et ai, 1989). Measles vaccine is also has been 
shown to be cost effective in Britain. 
Despite the success of the national vaccination programme in the United States 
in decreasing mortality due to vaccine-preventable diseases, vaccination rates 
remains sub optimal. In 1999, among children aged 19 to 35 months, 940/0 had 
received 3 or more doses of Hib vaccine, 83% had received 4 doses of 
dipthteria, tetanus toxoid and pertussis vaccine (OPT) or DT, and 78 % had 
completed 4 doses of OPT, 3 doses of poliovirus vaccine, 3 doses of Hib and 1 
dose of measles containing vaccine (Zimmerman et ai, 2000). 
Compliance with recommended schedules of immunisation in early childhood is 
not always complete, thus limiting the efficacy of these vaccines (Tift & 
Lederman, 1988). Immunisation of preschool children is intended to provide 
early protection to this most vulnerable group. One of the most important 
features of a successful vaccination programme is acceptability of the vaccines 
to both children and parents (Dittmann, 1999). A number of factors contribute to 
delayed completion of childhood immunisation series. 
Unimmunised preschool children are at risk for vaccine-preventable diseases 
and may serve as an important reservoir of infectious disease in the community. 
Disease transmission in unvaccinated children has been well documented 
during measles epidemics (Frank et ai, 1988; Bennish et ai, 1986; Hutchins et 
ai, 1989). The resurgence of measles in the US between 1989 and 1991 was 
associated with 55,622 reported cases, 11 ,251 hospitalisation and 166 
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suspected deaths from measles (Ad Hoc Working Group for development of 
standards for paediatric immunisation practice, 1993). In a measles outbreak in 
Dade country, Florida, overall 96 out of 257 cases (37%) were preventable 
(Hutchins et ai, 1989). However, 840/0 (79) of cases occurred in unimmunised 
preschool age children who were eligible for measles immunisation and thus 
preventable (Hutchins et ai, 1989). 
One of the goals of Healthy People 2000 of US Department of Health and 
Human Services (1990) is to adequately immunise 90% of children by their 
second birthday, meaning that they are fully vaccinated with four doses of 
diphteria, tetanus, pertussis vaccine (OPT), three doses of oral poliovirus (OPV) 
and one dose of measles, mumps and rubella combination (MMR) vaccine. The 
US has taken pride in its achievements in immunisation. By the early 1980s, 
more than 95% of school aged children were completely immunised and 
incidence rates for vaccine-preventable diseases had fallen by more than 900/0 
from prevaccination era (Cutts et ai, 1992). Although the immunisation rate of 
children at school entry in US approaches this goal of 900/0 (Zell et ai, 1994), 
only 44 to 60 % of children have received all routinely recommended 
immunisations by their second birthday (Bobo et ai, 1993; Zell et ai, 1994). 
Most children in the US have received their full vaccination series by the time 
they enter elementary school because prematriculation vaccination is mandated 
by law, but many are at risk of disease during preschool years because they do 
not receive their immunisations according to childhood vaccination guidelines. 
Immunisation at school entry is not adequate to eliminate measles in densely 
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populated areas and is too late to prevent diseases of infancy, such as 
Haemophilus influenzae meningitis. 
The World Health Organisation (WHO) has set a target for the year 2000 for the 
protection of all children by immunisation; it argues that a decision to withhold 
immunisation should be taken only after serious consideration of the potential 
consequences for the individual child and the community (WHO, 1984). 
In Britain, only a handful of health districts have achieved the 90% coverage for 
measles and no district has reached 90% coverage for dipthteria, pertussis and 
tetanus vaccination (Nicoll et ai, 1989). 
In the adult United States population, lack of compliance with immunisation 
recommendations has been implicated as a significant impediment to the 
success of pneumococcal and influenza vaccines (Fedson et ai, 1984). A 
promising approach to increase compliance is the establishment of hospital-
based immunisation programmes (Ratner et ai, 1983). 
The key to a successful immunisation programme lies in ensuring a high degree 
of compliance in children of preschool age. During the first two years of life, the 
child immunisation schedule recommended in Malaysia specifies that Hepatitis 
B should be given at birth, 1 and 5 months of age, BeG at 0 month (at birth or 
before discharge home), OPT and Sabin oral polio vaccine at 3, 4 and 5 
months, measles vaccine at 9 months of age and OPT booster at 18-24 months 
(Recommendations of the National Workshop on Practical Immunisation, 1990). 
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In Malaysia, the coverage of vaccination had increased from 1986-1998 (Table 
2). 
Table 2. Vaccination coverage in Malaysia between 1986-1998 
Year BeG OPT (3"') OPV (3'°) Hepatitis (3"') Measles 
1986 NA 62.2% 62.2% NA NA 
1989 NA 84.1% 83.3% 69.0% 60.9% 
1990 NA 89.9% 89.6% 86.2% 70.1% 
1991 NA 91 .6% 91.4% 88.8% 79.8% 
1993 NA 90.8% 90.8% 86.5% 81 .1% 
1994 NA 94.5% 93.8% 89.6% 84.9% 
1995 NA 93.7% 93.5% 90.7% 85.5% 
1996 NA 92.9% 92.3% 87.4% 84.2% 
1997 NA 93.0% 91.4% 88.8% 84.3% 
1998 100.0% 93.9% 93.4% 91 .1% 86.2% 
*data from MalaYSian MOH annual report 1990, 1991, 1996, 1997, 1998. 
Immunisation status of children is regarded as a hallmark of preventive 
medicine and health maintenance. Furthermore, some authors considered the 
vaccination rates as the indicator for adequacy of health care delivery. 
Rodewald et al (1995) found that underimmunisation was a powerful 
independent marker for inadequate health supervision in young children. 
1.2 Routine childhood vaccination 
1.2.1 Hepatitis B vaccine 
Between 128,000 and 320,000 persons were estimated to be infected with 
hepatitis B virus (HBV) annually in the US and approximately 6,000 persons die 
annually of HBV-related liver disease (Zimmerman et ai, 2000). Most of the 
deaths occur in persons with chronic HBV infection and are due to cirrhosis or 
primary hepatocellular carcinoma. 
This type of infection is much more likely to become chronic when acquired 
early in life than during adulthood. Chronic HBV infection develops in 900/0 of 
those infected as infants, 300/0 to 600/0 of those infected before the age of 4 
years, and only 5% t0100/0 of those infected as adults (Zimmermann et ai, 
2000). 
Although the endemic areas for hepatitis B infection vary throughout the world, 
overall it causes a huge economic burden and has a significant impact on 
health, causing about one million deaths each year (Dittmann, 1999). 
Furthermore, chronic hepatitis B infection is the most common cause of 
hepatocellular carcinoma worldwide (Schafer et ai, 1999). Despite the 
seriousness of hepatitis a, 85-950/0 of cases can be prevented by vaccination 
(Dittmann, 1999). 
Currently, more than 100 countries have introduced hepatitis B immunisation 
programmes and it has been calculated that in 1997, the programmes 
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prevented 483,000 deaths in human (Dittman, 1999). In Shanghai, vaccination 
has reduced the hepatitis B carrier rate from 3-13% to about 1 %, and rates in 
other countries have decreased by 30-400/0. In Taiwan, for example, the 
incidence in children aged 6-14 years has already fallen by about 500/0 (Chang 
et ai, 1997). 
The prevalence of HBV infection and its associated morbidity and mortality have 
led to the development of a comprehensive hepatitis B vaccination policy that 
includes recommendations for prevention of perinatal HBV infection, routine 
infant vaccination, catch-up vaccination of adolescents not previously 
vaccinated, catch-up vaccination of young children at risk for infection and pre-
exposure vaccination of adolescents and adults on the basis of lifestyle or 
environmental, medical and occupational situations that place them at risk. 
In Malaysia, Hepatitis B vaccines are routinely given to all infants regardless the 
status of Hepatitis B infection of the mother. The Hepatitis B immunisation was 
integrated into the Expanded Programme of Immunisation (EPI) in 1989. 
Malaysia is one of the first country in the world to start a national programme for 
Hepatitis B immunisation (MOH Malaysia annual report 1991). An intensive 
training programme was carried out to involve the midwives in the programme. 
The National Hepatitis Control Programme began in 1989 with the initiation of 
the National Immunisation Programme for hepatitis B for identified high-risk 
groups like newborns, health and medical personnel's, intravenous drug 
abusers and eligible blood donors. The objective of the programme was to 
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reduce the morbidity and prevent the spread of the disease and the carrier rate 
(MOH Malaysia annual report, 1997). 
The incidence rate of Hepatitis B in Malaysia has decreased markedly from 6.78 
per 100,000 population in 1988 to 1.26 per 100,000 population in 1997 (MOH 
Malaysia annual report, 1997). It was generally associated with the increased in 
strategies for prevention of hepatitis Band HIV I AIDS. 
The Hepatitis B vaccination policy was made because the prevalence of HBV 
infection was high especially in Southeast Asia, Taiwan and other oriental 
countries. The other possible reasons to recommend routine infant vaccination 
against HBV include the following: (1) morbidity and mortality of HBV infection, 
especially when contracted in childhood; (2) transmission of HBV infection from 
child to child, although relatively infrequent, has been reported in schools, 
daycare centers, families and among playmates (Franks et ai, 1989; Hurie et ai, 
1992; Zimmerman et ai, 2000); (3) strategies focusing on immunisation of high 
risk persons have had little impact; (4) no risk factors for HBV infection can be 
identified in at least 30010 of infected persons (Alter et ai, 1990; Zimmerman et 
ai, 2000); (5) routine infant hepatitis B vaccination is as cost-effective as other 
commonly used preventive measures (Zimmerman et ai, 2000). 
Pre-exposure vaccination results in protective antibody levels in almost all 
infants and children (>950/0) (Zimmerman et ai, 2000). The infant hepatitis B 
vaccination schedule depends on the mother's HbsAg status. For infants born 
to mothers with positive HbsAg, post exposure prophylaxis including both HBIG 
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and hepatitis B vaccine should be initiated within 12 hours of birth, regardless of 
gestational age. These infants should receive their second and third doses of 
vaccine at ages 1 month and 6 month respectively. For infants born to HbsAg 
negative mothers, the schedule is 0-2 months for first dose, 1-4 months for 
second, and 6-18 months for the third dose (Zimmerman et ai, 2000). 
1.2.2 Pertussis Vaccine 
Pertussis is transmitted by respiratory droplets and occasionally by contact with 
freshly contaminated objects. Pertussis is highly contagious; from 700/0 to 1000/0 
of susceptible household contacts and 50% to 800/0 of susceptible school 
contacts will become infected after exposure to a person who is contagious 
(Zimmerman et ai, 2000). 
Almost half (470/0) of reported cases of pertussis occur in infants, most reported 
cases (72%) occur in children younger than 5 years (Farizo et ai, 1992). The 
hospitalisation rate is 69% for reported cases of pertussis in infants younger 
than 12 months (FarizQ et ai, 1992). The case fatality rate is 0.6% for infant 
younger than 12 months. Pneumonia occurs in approximately 15% of pertussis 
cases and is the leading cause of death from pertussis (Farizo et ai, 1992). 
In Malaysia, since 1984 an average of 100 cases of pertussis have been 
reported every year until 1987. From 1988 to 1995, the incidence rate has 
decreased and about 25 cases were reported every year (MOH Malaysia 
annual report, 1995). The incidence rate of pertussis in 1996 was 3 per 100,000 
. 10 
and there were 3 reported cases of pertussis in 1997 (incidence rate 0.01) but 
the were no reported fatalities (MOH Malaysia annual report, 1997). 
In studies conducted in the US, OPT vaccination was found to be 700/0 and 900/0 
effective in preventing pertussive disease (Blennow et ai, 1990; Zimmerman et 
ai, 2000). Completing the recommended series for OPT is important for optimal 
efficacy. For example, one study found that the efficacy of whole cell vaccine 
based on a case definition of a cough of at least 14 days with paroxysms, 
whoop or vomiting is 36% after one dose, 490/0 after 2 doses and 83% after 3 
doses (Onorato et ai, 1992). 
The protection afforded by pertussive vaccination wanes with time (Mink et ai, 
1994). For DTP vaccines, protection against pertussive disease is lost by 12 
years after the last dose (Zimmerman et ai, 2000). 
Accellular pertussis vaccines have been licensed for use in infancy. Studies 
have shown that it is as efficacious as whole cell vaccine but has lower rates of 
adverse reactions than whole cell vaccine (Annunziato et ai, 1994). 
1.2.3 Tetanus Toxoids 
The incidence of neonatal tetanus has declined dramatically in industrialised 
countries owing to the introduction of effective immunisation, improved living 
standard and the introduction of clean delivery technique (Bart et ai, 1990). 
Historically, neonatal tetanus has been a silent killer in the developing world as 
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most deaths occurred at home and families often are reluctant to report 
neonatal deaths, so the problem was underestimated and often overlooked. 
The incidence rate of neonatal tetanus in Malaysia was 0.11 per 100,000 in 
1996 and 0.07 per 100,000 in 1997 (MOH Malaysia annual report, 1997). In 
some countries, neonatal tetanus accounts for as much as 500/0 of all neonatal 
death and probably accounts for 80% of all preventable death (Bart et ai, 1990). 
To control neonatal tetanus, immunisation of women of childbearing age is 
recommended (especially pregnant women), and a hygienic delivery and post 
delivery care should be assured. High coverage with tetanus toxoid has been 
remarkably successful in preventing neonatal tetanus (Black et ai, 1980). 
Neonatal tetanus serves an important index of the quality and extent of 
utilisation of maternal health services. The occurrence of even a single case is 
considered by WHO as failure of the health care delivery system. 
In Malaysia, OPT vaccines are given to infants at 3,4 and 5 months and a 
booster of OPT at 18-24 months. An additional booster of DT is given at 
standard 1 (7 years old) and a TT booster is given again at form 3 (15 years 
old). In addition, a TT booster is given to all pregnant women or following minor 
injury (Practical Immunisation Recommendations, 1990). 
Studies done in developed countries revealed that immunisation of an infant 
with 3 doses of OPT vaccines provide tetanus immunity for 1-3 years. 
Reinforcing immunisation with a booster dose given between 15-24 months of 
life prolongs tetanus immunity until 6-7 years of age. A fifth dose of tetanus 
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toxoid (TT) at school entry provides immunity until 17 -18 years of age. An 
additional dose on leaving school or during military services will ensure 
sufficient immunity for at least 2 more decades (Christenson et ai, 1987). 
In certain countries, for example in Tanzania, DPT vaccines are given earlier in 
infancy at 4, 8 and 12 weeks of age. Aboud et al (2000) studied the levels and 
avidity of antibodies to tetanus toxoids among 138 apparently healthy children 
aged 1-15 years in Tanzania. They found that OPT immunisation schedules that 
were given early in infancy as in Tanzania do provides adequate tetanus 
immunity for children below 5 years of age. However, about half of the older 
children (6-15 years of age) had no protection against tetanus. 
1.2.4 Diphteria 
Since the introduction of Diphteria Immunisation Programme in 1955, there has 
been a decline of major outbreaks of diphteria (MOH Malaysia annual report, 
1991). Only a few states have reported cases, which have been occurring 
among unimmunised children. The number of diphteria cases has shown a 
decreasing trend. The incidence rate of diphteria in 1991 was 0.06 per 100,000 
population and the incidence rate in 1997 was 0.01 per 100,000 population 
(MOH Malaysia annual reports, 1991 and 1997). 
Low immunisation coverage, poor socioeconomic conditions and occasional 
reported outbreaks suggest that diphteria remains an important preventable 
disease in much of the world. In most countries immunisation is carried out 
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during the first year of life using 3 doses of OPT. Many countries including 
Malaysia administer a booster dose at 18-24 months and at school entry. 
Persons aged 7 years or older should receive adult tetanus and diphteria 
toxoids (Td), which contain about the same quantity of tetanus toxoid as OPT or 
peadiatric DT vaccines but only one third to one eleventh as much diphteria 
toxoid (Zimmerman et ai, 2000). Td vaccine should be used for the primary 3-
dose series in those receiving the first dose at 7 years or older and for routine 
booster doses every 10 years. 
1.2.4 Poliovirus vaccine 
Poliomyelitis is caused by infection with one of the three types of poliovirus. All 
the three types of poliovirus are capable of causing paralysis. The poliovirus 
belongs to the enterovirus group. The poliovirus infects only human beings and 
there is no animal reservoir. Transmission occurs only from person to person, 
primarily by the fecal-oral route, particularly in areas where sanitation is poor. In 
countries with a high level of sanitation, pOlio is transmitted principally by the 
respiratory route (WHO, 1993). Infants and children less than 5 years of age are 
most frequently affected (WHO, 1993). Once a person is infected with a specific 
type of poliovirus, immunity to that type is life-long. 
In 1988, the WHO committed itself to the eradication of poliomyelitis from the 
world by year 2000. Although this goal may seem impossibly difficult, 
substantial progress has been made and 3 WHO regions (the Americas, Europe 
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and Western Pacific) appear free of indigenous wild poliovirus transmission 
(WHO weekly epidemiological report, 2000). Wild poliovirus was last reported in 
Europe in a child with onset of paralysis in November 1997 (WHO weekly 
epidemiological report, 2000). 
Member countries of South .. East Asia region of WHO (Bangladesh, Bhutan, 
Korea, India, Indonesia, Maldives, Myanmar, Nepal, Sri Lanka and Thailand) 
began implementation of polio eradication strategies in 1994 (WHO weekly 
epidemiological report, 2000) and have achieved tremendous progress to date. 
However, the region contains the largest remaining reservoir of wild poliovirus in 
the world. In 1999, majority of polio cases globally were still reported from this 
region, i.e. 480/0 of reported polio cases and 620/0 of cases with wild poliovirus 
isolation (WHO weekly epidemiological report, 2000). 
Malaysia has otherwise free from polio in the last 10 years except in 1992 when 
there were 2 imported cases (MOH Malaysia annual report, 1997). The WHO 
has identified polio as the second disease after smallpox to be eradicated I 
eliminated. Strategies have been formulated for all the nations worldwide. The 
surveillance of acute flaccid paralysis (AFP) is an important activity that needed 
to be closely adhered according to the Global Polio Eradication Programme. 
Two types of polio vaccines are available for prevention of poliomyelitis; oral, 
live poliO vaccine or OPV (Sabin) and injection polio vaccine or IPV (Salk). IPV 
is inactivated, cannot cause poliomyelitis and thus 
immunocompromised persons and contacts of those 
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is safe for 
persons. The 
disadvantages of IPV include administration by injection and less 
gastrointestinal immunity. An all IPV vaccination schedule results in the lowest 
risk of vaccine-associated paralytic poliomyelitis (VAPP). 
OPV has the advantage of easier administration; given by mouth and the cost is 
relatively low. The most important advantage of OPV is that it produces 
intestinal immunity thus preventing spread of wild poliovirus to other children. 
The main disadvantage of OPV is that the oral polioviruses can revert to a more 
virulent form and cause VAPP. OPV is recommended by the WHO for global 
eradication efforts and provides the earliest mucosal immunity. 
In 1999, 38 countries of European region relied on OPV only for their routine 
infant vaccination programme, 7 countries used IPV exclusively, and 6 countries 
used sequential IPV-OPV immunisation schedules (WHO weekly 
epidemiological report, 2000). Malaysia is still using OPV only for routine 
vaccination. In developing countries, three doses of OPV are 80-85% effective 
in preventing paralytic polio (WHO, 1993). 
1.2.5 Measles vaccine 
Measles is transmitted person to person by respiratory droplets and also by 
smaller aerosolised droplets that can spread through ventilation systems within 
a building and are infective for at least 1 hour (Remington et ai, 1985). 
Prodromal symptoms appear 10 to 12 days after exposure and the 
characteristic rash appears in 14 days. Infected persons may transmit the 
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disease 4 days before and 4 days after the appearance of the rash (Zimmerman 
et ai, 2000). 
Measles is a highly contagious disease. Following measles vaccination, 
seroconversion rates are 950/0 for children vaccinated at age 12 months and 
98% for children vaccinated at 15 months (Zimmerman et ai, 2000). The 
vaccine induce both humoral and cellular immunity. Antibody persists for at 
least 17 years and probably lifelong in almost all vaccinated persons who 
initially seroconvert. Subclinical reinfection may occur following vaccination, but 
there is no evidence that persons with subclinical disease transmit wild virus to 
others. 
There is significant association between measles vaccination coverage and 
measles attack rate (Schlenker et ai, 1992). Modest improvement in low levels 
of vaccination coverage among 2 years old confer substantial protection against 
measles outbreak (Schlenker et ai, 1992). 
Currently, ACIP in the US recommended a second dose of measles containing 
vaccine at age 4 to 6 years to provide protection for most of those who did not 
respond to initial measles vaccination (MMWR 1989). Inadequate protection 
from the first dose of measles vaccine most probably due to lack of initial 
seroconversion and waning immunity. In Finland, a comprehensive national 
vaccination programme was began in 1982 in which two doses of MMR were 
used, first dose at 14 to 18 months and the second dose at 6 years. Over a 12-
year period, an immunisation programme using two doses of MMR has 
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eliminated indigenous measles, mumps, and rubella from Finland (Peltola et ai, 
1994). 
The incidence rate of measles in Malaysia was 2.78 per 100,000 population in 
1997 (MOH Malaysia annual report, 1997). Measles vaccine has been shown to 
be effective in prevention of the disease. In Malaysia, measles vaccine was 
incorporated into the routine primary immunisation programme in 1984 (MOH 
Malaysia annual report, 1987) and it is given at 9 months in Malaysia as 
opposed to 12-18 months in many western countries. It is because of high 
prevalence of the disease in our country. 
1.2.6 BeG vaccine 
Tuberculosis is responsible for over 2 million deaths each year worldwide 
(WHO, 2001). The situation is further complicated in developing countries by 
the breakdown in health services, poorly managed programmes, the spread of 
HIV I AIDS and the emergence of multidrug resistance tuberculosis. 
Tuberculosis was declared as a global emergency by WHO in 1993 (WHO, 
2001). Control of this disease relies upon prevention through Bacillus Calmette-
Guerin (BCG) vaccination, preventive therapy (chemoprophylaxis) and the 
ascertainment and treatment of cases in particular employing the "directly 
observed therapy-short course" (DOTS) approach. 
BeG vaccine is usually recommended in populations with annual incidence of 
tuberculosis exceeding 1% (Center for Disease Control, 1988). Since its 
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introduction in 1928, BCG has appeared to reduce the risk of serious 
disseminated disease and dreadful complications of primary tuberculosis in 
children. However, the protective mechanisms of BeG vaccine are not fully 
understood. Its efficacy around the world is very variable and has remained 
controversial. Although BCG vaccines are among the most widely used 
vaccines in the world, pOlicies for their use differ between countries, and there is 
controversy concerning their efficacy and impact. The protective efficacy of 
BCG has ranged from 0 to 800/0 (Colditz et ai, 1995: WHO, 2001). 
BCG was incorporated into infant vaccination schedule of the Expanded 
Programme on Immunisation (EPI) in 1974 (WHO, 2001). Approximately 100 
million children now receive a BeG vaccine every year (WHO, 2001). BCG 
vaccination pOlicies differ greatly between countries. The various policies may 
be broken down into 4 groups: 
(1) BCG only at birth (or first contact with health services) 
This is the current recommendation of WHO, and it is a policy in 
i most of the world today, in particular in developing countries 
, 
i including Malaysia. WHO emphasized this policy in recent 
; years, because of consistent evidence that BeG protects 
. against serious childhood forms of tuberculosis, even where it 
; may not protect to a high degree against adult pulmonary forms 
: of the disease. 
, j 
(2) BeG once in childhood 
(3) Repeated I booster BCG 
(4) No routine BeG 
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1.3 Reasons for delayed I incomplete immunisation 
Recommendations to reduce missed opportunities have been summarised in 
the Standards for Pediatric Immunisation Practices (Ad Hoc Working Group for 
Development of Standards for Pediatric Immunisation Practice, 1993) which 
stated that providers should use all clinical encounters to screen and immunise 
children and follow only true vaccine contraindications when withholding 
vaccinations. A necessary component of implementation of this 
recommendation is the ability to assess the immunisation status of children 
during clinical encounters either during admission or during clinic visits. The 
immunisation status of the non-sick children accompanying the siblings or 
parents to health care visit should also be assessed (Ad Hoc working Group for 
Development of Standards for Pediatric Immunisation Practice, 1993). 
Many barriers to immunisation exist. Low immunisation coverage has been 
attributed to difficulties in reaching certain groups in population (Ewert et ai, 
1991; McConochie et ai, 1992; Wood et ai, 1995; Kenyon et ai, 1998). Other 
factors include inaccessibility of clinics and staff to administer the vaccine, high 
cost of both vaccine and delivery of vaccine, parental attitudes and 
misconceptions regarding timing, risk and benefit of immunisation (Watson et ai, 
1996). Parents seeking immunisation for their children face significant barriers 
and obstacles that impede vaccine delivery. 
In addition, many health care personnels fail to recognise and take advantage 
of all opportunities to immunise them either because of failure to screen the 
immunisation status of a child during a health care visit or the failure to 
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administer simultaneously all vaccines for which a child is eligible. This is called 
missed opportunities, which is defined as medical encounters during which a 
child is eligible but fails to receive an immunisation. Missed opportunities have 
been shown to occur in several circumstances: 
(1) when needed vaccines are not given simultaneously 
(McConnochie et ai, 1992 ; Tift & Lederman, 1988) 
(2) in emergency department (McConnochie et ai, 1992) and inpatient 
settings (Tift & Lederman, 1988 ; Riley et ai, 1991) 
(3) during non emergency visits to health care providers (Loevinsohn 
et ai, 1989; Hutchins et ai, 1989; McConnochie, 1992; Szilagyi, 
1993). 
However, without appropriate documentation of previous immunisations, 
opportunity to immunise cannot be fully optimised even when the health care 
provider is acutely aware of the available opportunity. To screen and 
subsequently immunise patients, the provider must be able to access the 
patient's medical record or rely on caregiver's recall of immunisation history. In 
the absence of immunisation documentation, the provider must vaccinate either 
arbitrarily or not at all. 
Opportunities to immunise children often are frequently missed because of lack 
of immunisation history (Watson et ai, 1996). In the study, they found that in one 
third of their new patients, the opportunities to immunise were missed solely 
because their immunisation records were not available at the initial visit. 
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In a busy primary care practice, it may not be easy to eliminate missed 
opportunities for immunisations. Potential barriers include practice pOlicies to 
administer immunisations only during scheduled well-child care or nursing visits 
(Szilagyi et ai, 1994); insufficient time to vaccinate children during acute illness 
or follow-up visits (Szilagyi et ai, 1994); knowledge deficits about inappropriate 
vaccine contraindications during concurrent minor illness (Hutchins et ai, 1989; 
Szilagyi et ai, 1994; Hugart et ai, 1994) or neurological conditions (Campbell et 
ai, 1994); concerns about multiple vaccinations (Hutchins et ai, 1989; Woodin et 
ai, 1995); failure to screen for immunisation status at illness encounters 
(Szilagyi et ai, 1994) and concern about impact of immunising children dUring 
acute-illness visits on subsequent compliance with preventive visits ( Szilagyi et 
ai, 1994 ). 
Humiston et al {1993} recognised the inability of emergency departments to 
identify underimmunised patients accurately during acute-care visits. They were 
unsuccessful in their attempts to derive decision rules that could predict 
vaccination status and allow for immediate intervention. McConnochie et al 
(1992) also recognized that at an emergency department visit, where 
immunisation records were not readily available, accounted for 180/0 of missed 
opportunities. 
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1.4 Risk factors 
Bobo et al in 1993 in a large community study of children from Oregon and 
Washington found that variables such as child's birth order, family income, 
maternal education and marital status significantly predicted failure to immunise 
on schedule. Compared with first-born children, later-born children were 1.7 
times more likely to be incompletely immunised at 2 years of age. Children of 
unmarried or poorly educated mothers with low income were more likely to be 
underimmunised. In Bangladesh, Zeit yin et al (1992), also showed similar 
findings whereby mothers' lack of education and low income were associated 
with poor compliance to immunisation. 
Roper et al (1986), found that low birthweight infants, less than 2000 9 at birth 
have considerable initial delay in uptake of immunisation compared with heavier 
babies, but by 18 months the coverage was almost identical. In his study, a 
similar delay was apparent when infants of 37 weeks' gestation or less were 
compared with babies born full term. Other reasons for delayed immunisation 
were highly mobile population, lack of motivation and frequent minor illnesses 
(Riley et ai, 1991). 
A study done by Mazidah et al (1995) in this community found that social and 
cultural factors contributed about 31 % of causes of delayed immunisation. The 
majority of children had delayed immunisation because of misconceptions to 
contraindications to immunisation (590/0), 310/0 by health personnel and another 
280/0 by mothers. Poor health care access contributed about 200/0. Another 
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29.5% were due to poor parental knowledge about immunisation. In the study, 
missed opportunities contributed about 50/0 of cases. 
In a local pilot study in hospitalised preschool children in the same hospital, 
Dinesh et al (1996) found that 18.8% of children had incomplete immunisation. 
They found that risk factors like sex, admission at birth, prematurity, working 
couples and frequent admissions showed some association with incomplete 
immunisation but were not statistically significant. A higher average distance of 
the clinic from residence and a lower maternal age were significantly associated 
with incomplete immunisation. 
Hospitalised preschool children, particularly those with chronic illnesses, have 
been shown to be underimmunised since the routine sequence of well-child 
visits for such children tends to be interrupted by visits for specific illnesses (Tift 
& Lederman, 1988; William et ai, 1996). Paediatric subspecialty patients had 
been shown to be at higher risk of incomplete immunisation than general 
paediatric patients or surgical subspecialty patients (Tift & Lederman, 1988). 
This is more so if the hospital, which they visited failed to use the opportunities 
to immunise them at the time of hospital discharge, despite the lack of 
contraindications. 
Fulginiti (1988) suggest that it would be simple to introduce a policy that all 
children admitted to hospitals will be screened for their immunisation status and 
any deficiencies will be corrected there and then, or planned after discharge 
from hospital. The idea is simple but it applications is difficult. Success would 
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